XENE
Xenon Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
XENE Filings
Filing Date
Form Description
Form Type
2026-03-13
Form 144 - Report of proposed sale of securities
Ownership
2026-03-13 · Ownership
Form 144 - Report of proposed sale of securities
2026-03-13
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-03-13 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-03-13
Form 8-K - Current report
Key Events
2026-03-13 · Key Events
Form 8-K - Current report
2026-03-13
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-03-13 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-03-13
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-03-13 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-03-13
Form 144 - Report of proposed sale of securities
Ownership
2026-03-13 · Ownership
Form 144 - Report of proposed sale of securities
2026-03-13
Form 144 - Report of proposed sale of securities
Ownership
2026-03-13 · Ownership
Form 144 - Report of proposed sale of securities
2026-03-12
Form 8-K - Current report
Key Events
2026-03-12 · Key Events
Form 8-K - Current report
2026-03-12
Form 424B5 - Prospectus [Rule 424(b)(5)]
2026-03-12 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
2026-03-11
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-03-11 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
